Company / Free Cash Flow
Dare Bioscience, Inc. Free Cash Flow History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$4.9M
FY2025
5-year range
-$39.5M / $4.9M
FY2021-FY2025
Trend
+112.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 7 years, ranging from -$39M in FY2024 to $5M in FY2025.
Based on SEC 10-K filings.
$5M in FY2025.
Improved from -$18M to $5M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 112.4% year-over-year.
- Lowest free cash flow in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.9M | +112.4% |
| FY2024 | -$39.5M | -117.5% |
| FY2023 | -$18.2M | +36.9% |
| FY2022 | -$28.8M | -49.2% |
| FY2016 | -$19.3M | -16.0% |
| FY2015 | -$16.6M | +21.5% |
| FY2014 | -$21.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026